From the Department of Orthopaedics, The Permanente Medical Group, Sacramento, CA (Dr. Dillon), Surgical Outcomes and Analysis, Kaiser Permanente, San Diego, CA (Dr. Prentice and Mr. Burfeind), and Department of Orthopaedics, Southern California Permanente Medical Group, San Diego, CA (Dr. Singh).
J Am Acad Orthop Surg. 2020 Dec 1;28(23):e1049-e1058. doi: 10.5435/JAAOS-D-19-00635.
Revision shoulder arthroplasty is an expensive undertaking with notable morbidity to the patient and less predictable outcomes. Therefore, it is important to avoid even further surgery in these patients. We sought to report the annual revision burden from a large integrated healthcare system and identify patient and operative factors that may predispose patients to revision failure, necessitating further surgery.
Annual revision burden as a proportion of the overall shoulder arthroplasties performed from 2005 to 2017 was obtained. Patients who underwent aseptic revision between 2005 and 2017 comprised the study sample. Patient characteristics evaluated for re-revision risk included age, sex, body mass index (BMI), race, and diabetes status, whereas surgical characteristics included surgeon cumulative revision volume, revision procedure type, and top reason for revision by primary procedure type. Multivariable Cox proportional hazards regression was used to evaluate the association between the specified factors and re-revision risk.
From 2005 to 2017, revisions represented 5.3% to 7.8% of all shoulder arthroplasty procedures performed. Factors associated with re-revision surgery risk by procedure type included increasing BMI and hemiarthroplasty revision procedure compared with reverse total shoulder arthroplasty (RTSA) revision procedure for hemiarthroplasty primaries; diabetes, revision because of instability, and lower cumulative surgeon revision procedure volume for RTSA primaries; and TSA revision procedure compared with RTSA revision procedure for TSA primaries.
The annual revision shoulder arthroplasty volume increased over the study period. Patient factors, including BMI and diabetes were associated with higher re-revision risks for hemiarthroplasty and RTSA primaries, respectively. RTSA revised for instability had a higher risk of re-revision compared with other indications. TSA and hemiarthroplasty requiring aseptic revision may be best treated with RTSA as opposed to another TSA or hemiarthroplasty. Further studies are needed to verify these findings and identify how the mechanism of failure may affect the procedure selection in the revision setting.
Level III.
肩关节翻修术费用昂贵,患者发病率高,且结果不可预测。因此,避免这些患者再次手术非常重要。我们旨在报告来自大型综合医疗系统的肩关节翻修年度再手术负担,并确定可能导致患者翻修失败、需要进一步手术的患者和手术因素。
获得了 2005 年至 2017 年期间进行的所有肩关节置换术的年度翻修负担比例。研究样本包括 2005 年至 2017 年期间进行的无菌性翻修患者。评估再次翻修风险的患者特征包括年龄、性别、体重指数(BMI)、种族和糖尿病状态,而手术特征包括外科医生累计翻修量、翻修手术类型以及按主要手术类型划分的翻修主要原因。多变量 Cox 比例风险回归用于评估指定因素与再次翻修风险之间的关系。
2005 年至 2017 年,翻修手术占所有肩关节置换术的 5.3%至 7.8%。按手术类型划分,与反式全肩关节置换术(RTSA)翻修相比,与肱骨头置换术(HAs)翻修相关的再次手术风险因素包括 BMI 增加和半肩置换术翻修;RTSA 原发性的糖尿病、不稳定和外科医生累计翻修手术量较低;以及相对于 RTSA 翻修术,全髋关节置换术(THA)翻修术。
在研究期间,肩关节翻修年度翻修量增加。患者因素,包括 BMI 和糖尿病,与 HA 和 RTSA 原发性更高的再次翻修风险相关。与其他适应证相比,因不稳定而接受 RTSA 翻修的患者再次翻修风险更高。需要无菌性翻修的 HA 和 RTSA 可能最好采用 RTSA 治疗,而不是另一种 THA 或 HA。需要进一步的研究来验证这些发现,并确定失效机制如何影响翻修环境中的手术选择。
III 级。